Premier providers of eye surgery and LASIK in Michigan and Northwest Ohio
Welcome to the first video in our Glaucoma Series with Dr. Alex Cherry, Fellowship Trained Glaucoma Specialist and Dr. David Bejot. This video discusses SLT / MLT Laser for first line treatment options.
Specialty Eye Institute is pleased to welcome Alexander Cherry, M.D. to the practice. Dr. Cherry is a Glaucoma and Cataract Specialist who is accepting new patients at the Adrian, Bryan and Toledo locations.
“SEI is very fortunate to add Dr. Cherry to our practice. As a fellowship trained glaucoma ophthalmologist, he is a highly skilled surgeon who will provide our patients, the greater Toledo area, and our referring doctors state-of-the-art care as a glaucoma and cataract surgeon,” says Dr. David Bejot, Clinical Optometric Director at Specialty Eye Institute.
Dr. Cherry grew up in the Toledo area and is a diehard Buckeyes fan. He graduated from Ohio State University College of Medicine and completed his residency and Glaucoma Fellowship at the University of Kentucky.
“I am very excited to be bringing expanded access to glaucoma services to the practice. It feels like a long time in the making to return to the Toledo area to practice and I cannot wait to get started,” states Dr. Cherry.
We are excited to announce Dr. Luis Gago and Dr. Kevin Lavery are now offering FDA approved corneal cross-linking treatment for progressive keratoconus and corneal ectasia following refractive surgery. To help you determine if this treatment is the correct option for you, we have created a list of the benefits and risks of a corneal cross-linking procedure.
“Corneal cross-linking is the only proven way to stabilize keratoconus and we are thrilled to be able to offer this procedure for our patients,” states Kevin Lavery, M.D., Cataract & Refractive Specialist at Specialty Eye Institute.
Avedro’s drug products, Photrexa® Viscous (riboflavin 5′-phosphate in 20% dextran ophthalmic solution) and Photrexa® (riboflavin 5′-phosphate ophthalmic solution) are indicated for use with the KXL System in corneal collagen cross-linking. It is a medical procedure that combines the use of ultra-violet (UV) light and riboflavin (vitamin B2) eye drops. The corneal cross-linking procedure works by creating new bonds between corneal collagen fibers which leads to the stiffening of corneas which have been weakened by disease or by refractive surgery.
“The corneal cross-linking procedure using riboflavin is the first and only FDA approved therapeutic treatment for patients with progressive keratoconus and corneal ectasia following refractive surgery. This can possibly save a patient from a more invasive corneal transplant procedure and is now covered by many insurance plans,” states Luis Gago, M.D., Cataract & Refractive Specialist at Specialty Eye Institute.
Appropriate patients over the age of 14 who have been diagnosed with progressive keratoconus or corneal ectasia following refractive surgery may be candidates for a procedure. Our team of ophthalmologists offer innovative corneal cross-linking procedures and treatments to clients. In addition, our doctors offer other types of eye care solutions such as cataract eye surgery, diabetic retinopathy treatments, LASIK surgery, hyperopia treatments, retinal detachment treatments, and refractive lens exchange surgery. Give our team a call by phone at (877) 852-8463 to discuss the advantages and risks of a corneal cross-linking procedure.
As part of our new clinic safety protocols our Facilities Manager Kevin has created and installed custom slit lamp shields in our offices. These shields offer an additional level of protection as the slit lamp is where patients/doctors are most vulnerable.
If you are interested in ordering custom-made slit lamp shield(s) for your office, you can order them for $20 each, the cost of the raw materials. To order, please complete the form below:
877-852-8463
Careers
Locations
Patient Portal
Request Appointment
877-852-8463
